Hangzhou Tigermed Consulting Reports FY Results
Shanghai Fosun Pharmaceutical Reports 1H Results
Shanghai Pharmaceuticals Holding Co., Ltd Goes Ex Dividend on Monday
Ardelyx Announces Acceptance Of New Drug Application For Tenapanor For Hyperphosphatemia In China; Triggers $2M Milestone Payment To Ardelyx Under The Terms Of The License Agreement Between Co And Shanghai Fosun Pharmaceutical Industrial Development Co.
Market Chatter: Fosun Pharma in Talks With Beijing Over Pfizer-BioNTech's COVID-19 Vaccine; Shares Fall 4%
Shanghai Fosun Pharmaceutical reports FY results